JPMorgan Chase & Co’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$63.2K Sell
6,080
-188,957
-97% -$1.96M ﹤0.01% 4994
2025
Q1
$2.57M Sell
195,037
-79,703
-29% -$1.05M ﹤0.01% 3103
2024
Q4
$4.92M Sell
274,740
-34,278
-11% -$614K ﹤0.01% 2762
2024
Q3
$4.98M Buy
309,018
+2,688
+0.9% +$43.3K ﹤0.01% 2645
2024
Q2
$8.27M Buy
306,330
+258,825
+545% +$6.99M ﹤0.01% 2225
2024
Q1
$926K Sell
47,505
-1,855
-4% -$36.2K ﹤0.01% 3621
2023
Q4
$1.02M Sell
49,360
-674
-1% -$13.9K ﹤0.01% 3517
2023
Q3
$1.59M Sell
50,034
-18,194
-27% -$579K ﹤0.01% 3141
2023
Q2
$2.29M Buy
68,228
+1,692
+3% +$56.9K ﹤0.01% 2962
2023
Q1
$2.77M Sell
66,536
-845
-1% -$35.2K ﹤0.01% 2841
2022
Q4
$2.29M Sell
67,381
-200
-0.3% -$6.78K ﹤0.01% 2880
2022
Q3
$3.32M Buy
67,581
+11,761
+21% +$578K ﹤0.01% 2605
2022
Q2
$2.19M Buy
55,820
+14,777
+36% +$581K ﹤0.01% 2945
2022
Q1
$1.51M Sell
41,043
-2,881
-7% -$106K ﹤0.01% 3359
2021
Q4
$4.3M Sell
43,924
-17,859
-29% -$1.75M ﹤0.01% 2692
2021
Q3
$7.71M Buy
61,783
+210
+0.3% +$26.2K ﹤0.01% 2262
2021
Q2
$7.72M Buy
61,573
+9,684
+19% +$1.21M ﹤0.01% 2345
2021
Q1
$7.04M Buy
51,889
+18,761
+57% +$2.55M ﹤0.01% 2397
2020
Q4
$3.01M Buy
33,128
+29,513
+816% +$2.68M ﹤0.01% 2721
2020
Q3
$278K Buy
3,615
+2,855
+376% +$220K ﹤0.01% 3606
2020
Q2
$65K Buy
+760
New +$65K ﹤0.01% 4121
2019
Q2
Sell
-8,524
Closed -$606K 4919
2019
Q1
$606K Sell
8,524
-16,465
-66% -$1.17M ﹤0.01% 3288
2018
Q4
$1.99M Buy
24,989
+4,254
+21% +$339K ﹤0.01% 2651
2018
Q3
$9.67M Sell
20,735
-349
-2% -$163K ﹤0.01% 1869
2018
Q2
$8.38M Buy
21,084
+670
+3% +$266K ﹤0.01% 1931
2018
Q1
$6.24M Buy
20,414
+5,870
+40% +$1.79M ﹤0.01% 2065
2017
Q4
$4.28M Buy
14,544
+2,373
+19% +$698K ﹤0.01% 2341
2017
Q3
$7.13M Buy
12,171
+209
+2% +$122K ﹤0.01% 1965
2017
Q2
$7.13M Buy
11,962
+3,816
+47% +$2.27M ﹤0.01% 1923
2017
Q1
$3.5M Sell
8,146
-525
-6% -$226K ﹤0.01% 2294
2016
Q4
$4.46M Sell
8,671
-1,592
-16% -$819K ﹤0.01% 2216
2016
Q3
$4.39M Buy
10,263
+220
+2% +$94K ﹤0.01% 2085
2016
Q2
$4.22M Buy
+10,043
New +$4.22M ﹤0.01% 2108